Horan Capital Advisors, Llc. Bristol Myers Squibb CO Transaction History

Horan Capital Advisors, Llc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $219,077 - $248,483	3,334 New	3,334 $231,000
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $170,914 - $204,941	2,780 New	2,780 $203,000
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $154,743 - $175,352	-2,680 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $153,912 - $170,555	2,680 New	2,680 $162,000
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $137,297 - $199,525	-2,959 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $2,608 - $3,402	-53 Reduced 1.76%	2,959 $190,000
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $128,823 - $152,738	3,012 New	3,012 $153,000
Q2 2019 Jul 26, 2019	SELL	$44.62 - $49.34 $134,395 - $148,612	-3,012 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$45.12 - $53.8 $135,901 - $162,045	3,012 New	3,012 $144,000
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $115,144 - $125,537	-1,921 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $106,096 - $122,444	1,921	1,921 $122,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Horan Capital Advisors, Llc. with notifications on news.